Literature DB >> 30730765

Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.

Yitan Zhu1, Abdallah S R Mohamed2,3, Stephen Y Lai2, Shengjie Yang1, Aasheesh Kanwar2, Lin Wei1, Mona Kamal2, Subhajit Sengupta1, Hesham Elhalawani2, Heath Skinner2, Dennis S Mackin2, Jay Shiao2, Jay Messer2, Andrew Wong2, Yao Ding2, Lifei Zhang2, Laurence Court2, Yuan Ji1,4, Clifton D Fuller2.   

Abstract

PURPOSE: Recent data suggest that imaging radiomic features of a tumor could be indicative of important genomic biomarkers. Understanding the relationship between radiomic and genomic features is important for basic cancer research and future patient care. We performed a comprehensive study to discover the imaginggenomic associations in head and neck squamous cell carcinoma (HNSCC) and explore the potential of predicting tumor genomic alternations using radiomic features.
METHODS: Our retrospective study integrated whole-genome multiomics data from The Cancer Genome Atlas with matched computed tomography imaging data from The Cancer Imaging Archive for the same set of 126 patients with HNSCC. Linear regression and gene set enrichment analysis were used to identify statistically significant associations between radiomic imaging and genomic features. Random forest classifier was used to predict the status of two key HNSCC molecular biomarkers, human papillomavirus and disruptive TP53 mutation, on the basis of radiomic features.
RESULTS: Widespread and statistically significant associations were discovered between genomic features (including microRNA expression, somatic mutations, and transcriptional activity, copy number variations, and promoter region DNA methylation changes of pathways) and radiomic features characterizing the size, shape, and texture of tumor. Prediction of human papillomavirus and TP53 mutation status using radiomic features achieved areas under the receiver operating characteristic curve of 0.71 and 0.641, respectively.
CONCLUSION: Our exploratory study suggests that radiomic features are associated with genomic characteristics at multiple molecular layers in HNSCC and provides justification for continued development of radiomics as biomarkers for relevant genomic alterations in HNSCC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30730765      PMCID: PMC6874020          DOI: 10.1200/CCI.18.00073

Source DB:  PubMed          Journal:  JCO Clin Cancer Inform        ISSN: 2473-4276


  38 in total

1.  miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue.

Authors:  Latha Ramdas; Uma Giri; Cheryl L Ashorn; Kevin R Coombes; Adel El-Naggar; K Kian Ang; Michael D Story
Journal:  Head Neck       Date:  2009-05       Impact factor: 3.147

2.  IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics.

Authors:  Lifei Zhang; David V Fried; Xenia J Fave; Luke A Hunter; Jinzhong Yang; Laurence E Court
Journal:  Med Phys       Date:  2015-03       Impact factor: 4.071

3.  Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.

Authors:  Neema Jamshidi; Maximilian Diehn; Markus Bredel; Michael D Kuo
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

4.  The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository.

Authors:  Kenneth Clark; Bruce Vendt; Kirk Smith; John Freymann; Justin Kirby; Paul Koppel; Stephen Moore; Stanley Phillips; David Maffitt; Michael Pringle; Lawrence Tarbox; Fred Prior
Journal:  J Digit Imaging       Date:  2013-12       Impact factor: 4.056

5.  MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression.

Authors:  Bo-Long Yu; Xiao-Hong Peng; Fei-Peng Zhao; Xiong Liu; Juan Lu; Lu Wang; Gang Li; Huai-Hong Chen; Xiang-Ping Li
Journal:  Int J Oncol       Date:  2014-01-28       Impact factor: 5.650

6.  CT imaging correlates of genomic expression for oral cavity squamous cell carcinoma.

Authors:  C R Pickering; K Shah; S Ahmed; A Rao; M J Frederick; J Zhang; A K Unruh; J Wang; L E Ginsberg; A J Kumar; J N Myers; J D Hamilton
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

7.  Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data.

Authors:  Wentian Guo; Hui Li; Yitan Zhu; Li Lan; Shengjie Yang; Karen Drukker; Elizabeth Morris; Elizabeth Burnside; Gary Whitman; Maryellen L Giger; Yuan Ji
Journal:  J Med Imaging (Bellingham)       Date:  2015-09-23

Review 8.  Apoptosis in cancer: from pathogenesis to treatment.

Authors:  Rebecca S Y Wong
Journal:  J Exp Clin Cancer Res       Date:  2011-09-26

9.  KEGG for integration and interpretation of large-scale molecular data sets.

Authors:  Minoru Kanehisa; Susumu Goto; Yoko Sato; Miho Furumichi; Mao Tanabe
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

10.  Comprehensive genomic characterization of head and neck squamous cell carcinomas.

Authors: 
Journal:  Nature       Date:  2015-01-29       Impact factor: 49.962

View more
  13 in total

1.  Are Artificial Intelligence Challenges Becoming Radiology's New "Bee's Knees"?

Authors:  Hesham Elhalawani; Raymond Mak
Journal:  Radiol Artif Intell       Date:  2021-04-21

2.  Introduction to Mathematical Oncology.

Authors:  Russell C Rockne; Jacob G Scott
Journal:  JCO Clin Cancer Inform       Date:  2019-04

3.  Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.

Authors:  Evangelia Katsoulakis; Yao Yu; Aditya P Apte; Jonathan E Leeman; Nora Katabi; Luc Morris; Joseph O Deasy; Timothy A Chan; Nancy Y Lee; Nadeem Riaz; Vaios Hatzoglou; Jung Hun Oh
Journal:  Oral Oncol       Date:  2020-06-30       Impact factor: 5.337

4.  A deep survival interpretable radiomics model of hepatocellular carcinoma patients.

Authors:  Lise Wei; Dawn Owen; Benjamin Rosen; Xinzhou Guo; Kyle Cuneo; Theodore S Lawrence; Randall Ten Haken; Issam El Naqa
Journal:  Phys Med       Date:  2021-03-10       Impact factor: 2.685

5.  Parallel comparison and combining effect of radiomic and emerging genomic data for prognostic stratification of non-small cell lung carcinoma patients.

Authors:  Ki Hwan Kim; Jinho Kim; Hyunjin Park; Hankyul Kim; Seung-Hak Lee; Insuk Sohn; Ho Yun Lee; Woong-Yang Park
Journal:  Thorac Cancer       Date:  2020-07-22       Impact factor: 3.500

Review 6.  Deep Learning in Head and Neck Tumor Multiomics Diagnosis and Analysis: Review of the Literature.

Authors:  Xi Wang; Bin-Bin Li
Journal:  Front Genet       Date:  2021-02-10       Impact factor: 4.599

7.  Differentiating low and high grade mucoepidermoid carcinoma of the salivary glands using CT radiomics.

Authors:  Michael H Zhang; Adam Hasse; Timothy Carroll; Alexander T Pearson; Nicole A Cipriani; Daniel T Ginat
Journal:  Gland Surg       Date:  2021-05

8.  Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma - Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes.

Authors:  Marta Bogowicz; Matea Pavic; Oliver Riesterer; Tobias Finazzi; Helena Garcia Schüler; Edna Holz-Sapra; Leonie Rudofsky; Lucas Basler; Manon Spaniol; Andreas Ambrusch; Martin Hüllner; Matthias Guckenberger; Stephanie Tanadini-Lang
Journal:  Front Oncol       Date:  2021-05-27       Impact factor: 6.244

9.  Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer.

Authors:  Hong-Yan Han; Jiang-Tao Mou; Wen-Ping Jiang; Xiu-Ming Zhai; Kun Deng
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

Review 10.  Radiomic biomarkers of tumor immune biology and immunotherapy response.

Authors:  Jarey H Wang; Kareem A Wahid; Lisanne V van Dijk; Keyvan Farahani; Reid F Thompson; Clifton David Fuller
Journal:  Clin Transl Radiat Oncol       Date:  2021-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.